Replies to post #3002 on NorthWest Biotherapeutics Inc (NWBO)

[Extremist223]

This is a great idea. Did any results come of this?

If it were reportable data, it would undermine the FDA and EMA trials. So I think this is the furthest NWBO can go in sharing compassionate use success. However, an investigative journalist might be able to get further with the medical staff in Israel, or former patients, if they were so inclined.

When speaking to the former patients in the compassionate use program, they might be willing to share what the medical staff thought about DCVAX